NRx Pharmaceuticals says FDA reclassified ANDA amendment as minor
NRx Pharmaceuticals said the FDA reclassified its ANDA amendment as a Minor Amendment and set a GDUFA goal date of Nov. 10, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.